Literature DB >> 28782273

Up-regulation of transient receptor potential vanilloid (TRPV) and down-regulation of brain-derived neurotrophic factor (BDNF) expression in patients with functional dyspepsia (FD).

C K Y Cheung1, L L Lan1, M Kyaw1, A D P Mak2, A Chan3, Y Chan1, J C Y Wu1.   

Abstract

BACKGROUND: The role of immune activation in Functional Dyspepsia (FD) patients without previous infection is unclear. We compare the gastric and circulating brain-derived neurotropic factor (BDNF), receptor potential vanilloid type (TRPV) families and various cytokines in FD patients.
METHODS: Consecutive adult FD patients (Rome III) with no recent history of gastroenteritis and asymptomatic healthy controls were recruited for upper endoscopy. Subjects with GERD and IBS as predominant symptoms, diabetes mellitus, current or previous Helicobacter pylori infection, psychiatric illness and recent use of NSAID or PPI were excluded. Corpus biopsies and serum samples were collected. KEY
RESULTS: Forty three [M:F=8:35, mean age: 35.0 (9.3)] FD patients were compared with 23 healthy controls [M:F=8:15, mean age: 36.6 (10.2)]. FD patients had postprandial distress syndrome (PDS) as predominant sub-type (PDS: 36, EPS: 2). There was no significant difference in the median inflammation score (FD:0 (0-1) vs Control:0 (0-1), P=.79). However, FD patients had significantly higher mRNA expression of TRPV1 (FD:0.014±0.007, Control:0.003±0.001, 4.6 fold, P=.02) and TRPV2 (FD:0.012±0.006, Control:0.003±0.001, 4 fold, P=.02) compared to controls. The serum (FD:258.0±12.3 ng ml-1 , Control:319.7±18.1 ng ml-1 , P<.01) and gastric BDNF mRNA (FD:0.06±0.008, Control:0.092±0.01, 0.65 fold, P=.02)levels significantly lower in FD patients. Secretion of cytokines (IL-4, IL-5, IL-6, IL-8, IL-10, G-CSF, TGF-β2, MCP-1)was also highly correlated with dyspeptic symptoms in patients with FD. CONCLUSIONS & INFERENCES: Despite lacking gastric mucosal inflammation, up-regulation of TRPV1 and TRPV2, down-regulation of BDNF were observed in FD patients. These suggest that immune alteration may contribute to the pathogenesis of FD without any previous infection.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990BDNFzzm321990; zzm321990TGFzzm321990; zzm321990TRPVzzm321990; dyspepsia; low-grade inflammation

Mesh:

Substances:

Year:  2017        PMID: 28782273     DOI: 10.1111/nmo.13176

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  7 in total

1.  Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test.

Authors:  Johann Hammer
Journal:  Am J Gastroenterol       Date:  2018-03-13       Impact factor: 10.864

2.  British Society of Gastroenterology guidelines on the management of functional dyspepsia.

Authors:  Christopher J Black; Peter A Paine; Anurag Agrawal; Imran Aziz; Maria P Eugenicos; Lesley A Houghton; Pali Hungin; Ross Overshott; Dipesh H Vasant; Sheryl Rudd; Richard C Winning; Maura Corsetti; Alexander C Ford
Journal:  Gut       Date:  2022-07-07       Impact factor: 31.793

3.  Integrating Network Pharmacology and In Vivo Model to Investigate the Mechanism of Biheimaer in the Treatment of Functional Dyspepsia.

Authors:  Chun Wang; Nuermanati Huanbieke; Xiaoxia Cai; Shuyan Gao; Tianfang Du; Ziqian Zhou; Zulipikaer Wusiman; Malikam Matturzi; Silafu Aibai; Zhi-Jian Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-27       Impact factor: 2.650

Review 4.  Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect.

Authors:  Matthias Ceulemans; Inge Jacobs; Lucas Wauters; Tim Vanuytsel
Journal:  Front Neurosci       Date:  2022-04-26       Impact factor: 5.152

Review 5.  Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift.

Authors:  Hye-Kyung Jung; Nicholas J Talley
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

6.  Precise and systematic survey of the efficacy of multicomponent drugs against functional dyspepsia.

Authors:  Junying Wei; Qiong Man; Feifei Guo; Minghua Xian; Tingting Wang; Chunyu Tang; Yi Zhang; Defeng Li; Daifeng Tang; Hongjun Yang; Luqi Huang
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

Review 7.  The Psychotic Impact of Helicobacter pylori Gastritis and Functional Dyspepsia on Depression: A Systematic Review.

Authors:  Asmaa M Al Quraan; Nitya Beriwal; Pema Sangay; Tashi Namgyal
Journal:  Cureus       Date:  2019-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.